Team:Slovenia/Notebook/References

From 2008.igem.org

(Difference between revisions)
(New page: <html> <head> <link rel="stylesheet" type="text/css" href="http://www.obrazuspeha.si/css_igem_slo08/default.css"> <!-- dd menu --> <script type="text/javascript"> <!-- var timeout ...)
 
(5 intermediate revisions not shown)
Line 78: Line 78:
<a href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</a>
<a href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</a>
<a href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</a>
<a href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Background/Immune_response" target="_self">Immune response</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Background/Flagellin" target="_self">Flagellin</a>
</div>
</div>
</li>
</li>
Line 94: Line 96:
<a href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a>
<a href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a>
<a href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">"Real-life" results</a>
<a href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">"Real-life" results</a>
-
<a href="https://2008.igem.org/Team:Slovenia/Results/Biobricks" target="_self">Biobricks</a>
+
<a href="https://2008.igem.org/Team:Slovenia/Results/Biobricks" target="_self">Biobricks</a>
</div>
</div>
</li>
</li>
Line 105: Line 107:
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</a>
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</a>
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</a>
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</a>
-
<a href="https://2008.igem.org/Team:Slovenia/Notebook/Timeline" target="_self">Timeline</a>
 
<a href="#" target="_self">References</a>
<a href="#" target="_self">References</a>
 +
                <a href="https://2008.igem.org/Team:Slovenia/Notebook/Notebook" target="_self">Notebook</a>
</div>
</div>
</li>
</li>
Line 114: Line 116:
-
<li><a href="https://2008.igem.org/Team:Slovenia/Sponsors" target="_self" ><img src="https://static.igem.org/mediawiki/2008/d/d4/Sponsors_btn.gif" width="103" height="30" border="0" /></a>
+
<li><a href="https://2008.igem.org/Team:Slovenia/Credits" target="_self" onmouseover="mopen('m5')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/d/d4/Sponsors_btn.gif" width="103" height="30" border="0" /></a>
 +
<div id="m5" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
 +
<a href="https://2008.igem.org/Team:Slovenia/Acknowledgements" target="_self">Acknowledgements</a>
 +
<a href="https://2008.igem.org/Team:Slovenia/Sponsors" target="_self">Sponsors</a>
 +
</div>
 +
</li>
</ul>
</ul>
<div style="clear:both"></div>
<div style="clear:both"></div>
Line 154: Line 161:
-->
-->
<html><center>
<html><center>
-
<font size="-1" color="#C73E4A"><i><b>References</b></i></font>  
+
<font size="6" color="#C73E4A"><i>References</i></font>  
</center></html>
</center></html>
Line 160: Line 167:
----
----
 +
Abbas A.K., Lichtman A.H. 2004. Basic immunology: Functions and disorders of the immune system. 2nd edition. Philadelphia, PA: W. B. Saunders Co.: 323
 +
 +
 
 +
 +
Akira S., Takeda K. 2004. Toll like receptor signalling.
 +
 +
Nature reviews, Immunology, 4, 7: 499-511
 +
 +
 +
 +
Akira S., Takeda K. 2005. Toll like receptors in innate immunity.
 +
 +
International immunology, 17, 1: 1-14
 +
 +
 +
 +
Aras R.A., et al. 2003. Plasticity of repetitive DNA sequences within a bacterial (type IV) secretion system component.
 +
 +
The Journal of Experimental Medicine, 198, 9: 1349–1360
 +
 +
 +
 +
Baldari C.T., Lanzavecchia A., Telford J.L. 2005. Immune subversion by Helicobacter pylori.
 +
 +
Trends in Immunology, 26, 4: 199-207
 +
 +
 +
 +
Blander J.M. 2007. Signalling and phagocytosis in the orchestration of host defence.
 +
 +
Cellular Microbiology, 9, 2: 290–299
 +
 +
 +
 +
Blander J.M., Medzhitov R. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells.
 +
 +
Nature, 440, 6: 808-812 
 +
 +
 
 +
 +
Blaser M.J., Atherton J.C. 2004. Helicobacter pylori persistence: biology and disease.
 +
 +
The Journal of Clinical Investigation, 113, 3: 321-333
 +
 +
 
 +
 +
Frenck RW, Clemens J. 2003. Helicobacter in the developing world.
 +
 +
Microbes and Infection, 5, 8: 705-13 
 +
 +
 +
 +
Gangwer K. A. et. all. 2007. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain.
 +
 +
PNAS, 104, 41: 16293-16298
 +
 +
 +
 +
Galkin et al., 2008 Divergence of quaternary structures among bacterial flagellar filaments.
 +
 +
Science 320, 5874:382-5
 +
 +
 +
 +
Gewirtz A. T., Yu Y., Krishna U.S., Israel D.A., Lyons S.L., Peek R.M., Jr. 2004. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity.
 +
 +
The Journal of Infectious Diseases, 189, 10: 1914-20
 +
 +
 +
 +
Guy B. 2007. The perfect mix: recent progress in adjuvant research.
 +
 +
Nature reviews  microbiology, 5, 7: 505-517
 +
 +
 +
 +
Hasan U.A. et al., 2004 .Differential induction of gene promoter constructs by constitutively active human TLRs
 +
 +
Biochem Biophys Res. Commun. 321, 124-131.
 +
 +
 +
 +
Israel D.A., Peek R.M. 2006. The Role of Persistence in Helicobacter pylori Pathogenesis.
 +
 +
Current Opininon in Gastroenterology, 22, 1: 3-7
 +
 +
 +
 +
Kanzler H. 2007. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature medicine, 13, 5: 552-559
 +
 +
 +
 +
Moran A.P., Aspinall G.O. 1998. Unique structural and biological features of Helicobacter pylori lipopolysaccharides.
 +
 +
Progress in clinical and biological research, 397: 37-49
 +
 +
 
 +
 +
Moran A.P., Lindner B., Walsh E. J. 1997. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides.
 +
 +
The Journal of Bacteriology, 179, 20: 6453-63
 +
 +
 +
 +
Nempont C. et. all. 2008. Deletion of Flagellin’s Hypervariable Region Abrogates Antibody-Mediated Neutralization and Systemic Activation of TLR5-Dependent Immunity.
 +
 +
The Journal of Immunology, 181, 3: 2036–2043
 +
 +
 
 +
 +
Querec T., Bennouna S., Alkan S., Laouar Y., Gorden K, Flavell R., Akira S., Ahmed R., Pulendran B. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.
 +
 +
The Journal of Experimental Medicine, 203, 2:  413–424
 +
 +
 +
 +
Sansonetti P.J., Di Santo J.P. 2007. Debugging how Bacteria Manipulate the Immune Response.
 +
 +
Immunity 26, 2: 149–161
 +
 +
 
 +
 +
Smith K.D., Andersen-Nissen E., Hayashi F., Strobe K., Bergman M.A., Barrett S.L., Cookson B.T., Aderem A. 2003. Toll-like receptor 5  recognizes a conserved site on flagellin required for protofilament formation and bacterial motility.
 +
 +
Nature Immunology, 4, 12: 1247-53
 +
 +
   
 +
 +
Tevž et al. 2008. Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression.
 +
 +
Technology in cancer research and treatment, 7, 2: 91-101
 +
 +
 
 +
 +
Wirth H.P., Yang M., Peek R.M., Jr., Tham K.T., Blaser M.J. 1997. Helicobacter pylori Lewis expression is related to the host Lewis phenotype.
 +
Gastroenterology, 113, 4: 1091-1098

Latest revision as of 04:45, 30 October 2008

Igem-logo-900x200-1-2.jpg



References


Abbas A.K., Lichtman A.H. 2004. Basic immunology: Functions and disorders of the immune system. 2nd edition. Philadelphia, PA: W. B. Saunders Co.: 323


Akira S., Takeda K. 2004. Toll like receptor signalling.

Nature reviews, Immunology, 4, 7: 499-511


Akira S., Takeda K. 2005. Toll like receptors in innate immunity.

International immunology, 17, 1: 1-14


Aras R.A., et al. 2003. Plasticity of repetitive DNA sequences within a bacterial (type IV) secretion system component.

The Journal of Experimental Medicine, 198, 9: 1349–1360


Baldari C.T., Lanzavecchia A., Telford J.L. 2005. Immune subversion by Helicobacter pylori.

Trends in Immunology, 26, 4: 199-207


Blander J.M. 2007. Signalling and phagocytosis in the orchestration of host defence.

Cellular Microbiology, 9, 2: 290–299


Blander J.M., Medzhitov R. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells.

Nature, 440, 6: 808-812


Blaser M.J., Atherton J.C. 2004. Helicobacter pylori persistence: biology and disease.

The Journal of Clinical Investigation, 113, 3: 321-333


Frenck RW, Clemens J. 2003. Helicobacter in the developing world.

Microbes and Infection, 5, 8: 705-13


Gangwer K. A. et. all. 2007. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain.

PNAS, 104, 41: 16293-16298


Galkin et al., 2008 Divergence of quaternary structures among bacterial flagellar filaments.

Science 320, 5874:382-5


Gewirtz A. T., Yu Y., Krishna U.S., Israel D.A., Lyons S.L., Peek R.M., Jr. 2004. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity.

The Journal of Infectious Diseases, 189, 10: 1914-20


Guy B. 2007. The perfect mix: recent progress in adjuvant research.

Nature reviews microbiology, 5, 7: 505-517


Hasan U.A. et al., 2004 .Differential induction of gene promoter constructs by constitutively active human TLRs

Biochem Biophys Res. Commun. 321, 124-131.


Israel D.A., Peek R.M. 2006. The Role of Persistence in Helicobacter pylori Pathogenesis.

Current Opininon in Gastroenterology, 22, 1: 3-7


Kanzler H. 2007. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature medicine, 13, 5: 552-559


Moran A.P., Aspinall G.O. 1998. Unique structural and biological features of Helicobacter pylori lipopolysaccharides.

Progress in clinical and biological research, 397: 37-49


Moran A.P., Lindner B., Walsh E. J. 1997. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides.

The Journal of Bacteriology, 179, 20: 6453-63


Nempont C. et. all. 2008. Deletion of Flagellin’s Hypervariable Region Abrogates Antibody-Mediated Neutralization and Systemic Activation of TLR5-Dependent Immunity.

The Journal of Immunology, 181, 3: 2036–2043


Querec T., Bennouna S., Alkan S., Laouar Y., Gorden K, Flavell R., Akira S., Ahmed R., Pulendran B. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.

The Journal of Experimental Medicine, 203, 2: 413–424


Sansonetti P.J., Di Santo J.P. 2007. Debugging how Bacteria Manipulate the Immune Response.

Immunity 26, 2: 149–161


Smith K.D., Andersen-Nissen E., Hayashi F., Strobe K., Bergman M.A., Barrett S.L., Cookson B.T., Aderem A. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility.

Nature Immunology, 4, 12: 1247-53


Tevž et al. 2008. Gene electrotransfer into murine skeletal muscle: a systematic analysis of parameters for long-term gene expression.

Technology in cancer research and treatment, 7, 2: 91-101


Wirth H.P., Yang M., Peek R.M., Jr., Tham K.T., Blaser M.J. 1997. Helicobacter pylori Lewis expression is related to the host Lewis phenotype.

Gastroenterology, 113, 4: 1091-1098






Retrieved from "http://2008.igem.org/Team:Slovenia/Notebook/References"